
Deepak R. Rao
Examiner (ID: 18986, Phone: (571)272-0672 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1611, 1202 |
| Total Applications | 3005 |
| Issued Applications | 2150 |
| Pending Applications | 168 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19373850
[patent_doc_number] => 12065399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Arylsulfonamide derivatives
[patent_app_type] => utility
[patent_app_number] => 17/672297
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12748
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672297 | Arylsulfonamide derivatives | Feb 14, 2022 | Issued |
Array
(
[id] => 17759929
[patent_doc_number] => 20220233541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => PYRUVATE KINASE MODULATORS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/586777
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586777 | Pyruvate kinase modulators and use thereof | Jan 26, 2022 | Issued |
Array
(
[id] => 18955054
[patent_doc_number] => 20240043381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/264538
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264538
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264538 | Crystalline 5-methoxy-dipropyl tryptamine compounds | Jan 24, 2022 | Issued |
Array
(
[id] => 18478256
[patent_doc_number] => 11691986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => PTEFB inhibiting macrocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/558390
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40929
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558390 | PTEFB inhibiting macrocyclic compounds | Dec 20, 2021 | Issued |
Array
(
[id] => 18793856
[patent_doc_number] => 11827608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators
[patent_app_type] => utility
[patent_app_number] => 17/556786
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 11976
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556786 | Method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators | Dec 19, 2021 | Issued |
Array
(
[id] => 17735110
[patent_doc_number] => 20220220569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => CATIONIC CYANURIC CHLORIDE DERIVATIVE TANNING AGENT AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/556206
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556206 | Cationic cyanuric chloride derivative tanning agent and preparation method thereof | Dec 19, 2021 | Issued |
Array
(
[id] => 17851786
[patent_doc_number] => 20220281828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/555786
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555786 | AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE | Dec 19, 2021 | Abandoned |
Array
(
[id] => 17641907
[patent_doc_number] => 20220169645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => COMPOUNDS AS BRUTON TYROSINE KINASE INHIBITORS, PREPARATION METHODS AND MEDICAL APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/540763
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 311
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540763
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/540763 | COMPOUNDS AS BRUTON TYROSINE KINASE INHIBITORS, PREPARATION METHODS AND MEDICAL APPLICATIONS THEREOF | Dec 1, 2021 | Abandoned |
Array
(
[id] => 18226635
[patent_doc_number] => 20230065629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/519329
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 197516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17519329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/519329 | SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF | Nov 3, 2021 | Abandoned |
Array
(
[id] => 17505079
[patent_doc_number] => 20220098181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
[patent_app_type] => utility
[patent_app_number] => 17/517428
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517428 | Compositions and methods for inhibition of the JAK pathway | Nov 1, 2021 | Issued |
Array
(
[id] => 17505097
[patent_doc_number] => 20220098199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => SYNTHETIC CO-CRYSTALS OF ANHYDROUS GUANINE AND PROCESS FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/504443
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17504443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/504443 | Synthetic co-crystals of anhydrous guanine and process for preparing the same | Oct 17, 2021 | Issued |
Array
(
[id] => 17385556
[patent_doc_number] => 20220033408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PROCESS FOR PREPARING SPIRO DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/502653
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502653 | PROCESS FOR PREPARING SPIRO DERIVATIVES | Oct 14, 2021 | Abandoned |
Array
(
[id] => 17533555
[patent_doc_number] => 20220112164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => HETEROCYCLIC G-PROTEIN-COUPLED RECEPTOR 52 (GPR52) AGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/499299
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499299 | Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists | Oct 11, 2021 | Issued |
| 17/447805 | DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF | Sep 14, 2021 | |
Array
(
[id] => 18138841
[patent_doc_number] => 20230012676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => TYROSINE KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/465662
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 431
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465662 | Tyrosine kinase inhibitors | Sep 1, 2021 | Issued |
Array
(
[id] => 17791975
[patent_doc_number] => 20220251066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/458862
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458862 | SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | Aug 26, 2021 | Abandoned |
Array
(
[id] => 18207813
[patent_doc_number] => 20230054070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SIGMA LIGAND COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/400207
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400207 | Sigma ligand compounds and uses thereof | Aug 11, 2021 | Issued |
Array
(
[id] => 17258433
[patent_doc_number] => 20210371418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => PROTEIN KINASE INHIBITORS, PREPARATION METHOD AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/444109
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/444109 | Protein kinase inhibitors, preparation method and medical use thereof | Jul 29, 2021 | Issued |
Array
(
[id] => 17214403
[patent_doc_number] => 20210347740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Prolyl Hydroxylase Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/383554
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383554 | Prolyl hydroxylase inhibitors | Jul 22, 2021 | Issued |
Array
(
[id] => 18518441
[patent_doc_number] => 11708319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducers
[patent_app_type] => utility
[patent_app_number] => 17/375882
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 18916
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17375882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/375882 | Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducers | Jul 13, 2021 | Issued |